Parabilis Soared Biggest Biotech: Is It Too Late to Buy?
A record biotech IPO backdrop has investors buzzing about Parabilis Medicines. This guide breaks down what the surge ...
Choosing which blue chip crypto to hold long term involves assessing fundamentals and market resilience. Prioritize quality, liquidity, and credible use cases.
28,075 articlesA record biotech IPO backdrop has investors buzzing about Parabilis Medicines. This guide breaks down what the surge ...
A Sunrun director recently disposed of a large block of shares. This article breaks down insider sales, what they imp...
As Guidewire charts its path through cloud adoption and insurer modernization, guidewire (gwre) 2026 earnings become ...
A mid-2026 pullback in amazon stock pulled back has investors weighing growth ambitions against profitability. This g...
This week brought a sharp turn for Zscaler investors. Despite beating earnings estimates, the stock moved lower as gu...
JPMorgan and Mastercard joined Ripple and Ondo Finance to settle a tokenized US Treasury redemption on the XRP Ledger...
A loomingFed policy shift could push up borrowing costs for households. Analysts warn americans taxpayers could face ...
A Daiwa Securities analyst labeled SpaceX’s valuation catastrophic, while options traders bought calls, signaling a b...
BigBear.AI delivers a stronger Q1 2026, expanding margins and backlog while signaling a ramp in defense contracts. Th...
Anthropic moved to disable access to its Fable 5 and Mythos 5 models after a U.S. export controls directive barred fo...
Looking for passive income that can edge toward 8% annual returns? This guide covers seven loan-based options, how th...
U.S. manufacturers grow second month in a row in February, but tariff-driven pricing pressures and volatile metal cos...